In diagnostic terms, both CD38 and SIRT1 exhibited higher discriminatory power than conventional renal markers such as serum urea or creatinine, underscoring their potential as early, sensitive biomarkers for DN staging. Here, CD38 is linked to liver dysplastic nodule.